Skip to main content

Even Just 4,000 Steps a Day Can Help You Live Longer

Getting just under 4,000 steps each day may be enough to lower a person’s risk of early death, researchers say—far less than the 10,000 steps many believe to be the optimal amount for health.The news comes from a new meta-analysis, published Wednesday in the European Journal of Preventive Cardiology. It's the world's largest study to date showing the importance of daily step counts. But researchers found that as few as 3,967 steps daily were enough to start reducing the risk of early death from all causes. That number dropped to just 2,337 daily steps to begin lowering the risk of death from cardiovascular disease. It doesn't stop there—with every extra 500 to 1,000 steps a day, the research showed that people can continue to reduce their risk of dying from cardiovascular disease or any cause, respectively. And scientists noted that they have yet to identify an upper limit to the benefits of walking; even at 20,000 steps per day, the health benefits only continued to increase. There's no clearly-established exact step goal; the classic 10,000 steps isn't necessarily data-backed," said Eric Brandt, MD, a cardiologist and lipidologist at the University of Michigan Frankel Cardiovascular Center, who was not involved in the new research. But "the more activity you can do, the better, and you're going to keep getting more and more benefit from it. How More Steps Impact Longevity In order to see how step counts and mortality risk were linked, researchers analyzed data from nearly 227,000 participants across 17 different studies around the world. All participants in the included studies, at the start, were considered generally healthy or had some possible risk factors of cardiovascular disease, such as high blood pressure, said Banach, who is also an adjunct professor at the Ciccarone Center for Prevention of Cardiology at Johns Hopkins University School of Medicine. Across all studies, participants had an average age of 64 years old, and 49% of participants were female. The included studies followed-up with participants after an average of seven years to see how step counts related to both cardiovascular mortality risk and all-cause mortality risk. The researchers identified a "significant inverse association between daily step count and all-cause mortality and [cardiovascular] mortality"—essentially, the more steps taken, the lower the risk of early death from any cause or heart issues. According to Barach, the minimum number of daily steps needed to start seeing longevity and survival benefits was 3,867; for a lower risk of death from cardiovascular disease in particular, that threshold was 2,337 steps. Notably, the findings were consistent across different demographic factors, Banach said. Cohorts were based in Japan, the U.S., the U.K., Australia, and other countries, and getting 4,000 steps a day was generally beneficial, regardless of their “climate zone.” The same was true, regardless of gender. “However, we noticed that the largest reduction of mortality was observed for younger individuals in comparison to older people,” Banach told Health. This could imply that increasing step counts earlier on in life could have an even greater effect. The analysis also didn't identify an upper limit for steps—though the data was limited, even among people who walked as many as 20,000 steps a day, the health benefits only continued to increase. Incorporating More Movement Into Your Daily Routine There are no firm public health guidelines regarding step counts at this point, but this study should be encouraging for people looking to improve their general health. Prior research has suggested that if a person doesn't get 5,000 steps per day, they were considered sedentary, Banach explained. This research essentially undermines that previous definition, study authors said. Even though it’s true that the more steps a person takes the better, people may feel “discouraged” if they can’t reach higher step goals, he said. Whether due to work or other constraints, the concern is that people won’t bother with getting more steps in since they feel out of reach. Whether it’s measured in minutes or steps, simple things such as walking a dog, walking to appointments instead of driving, or parking further away from the door can all add more movement into a person’s day to day, Brandt and Banach said. And it can also be easier to work in terms of averages, Banach added. “[It] doesn’t mean that you need to have, for example, 7,000 or 6,000 steps every day. It means that you should have 6,000 steps per day on average,” he said. “If you do not have time to increase the number of steps during the week, try to be proactive during the weekend.” The overall findings suggest that, as helpful and essential as medications and treatments are to improve health, lifestyle changes—like diet and exercise—matter just as much, if not more. "In a world where we have more and more advanced drugs to target specific conditions such as cardiovascular disease," Banach said in the news release, "I believe we should always emphasize that lifestyle changes, including diet and exercise [...] might be at least as, or even more effective in reducing cardiovascular risk and prolonging lives."

Comments

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...